Giorgio Frega, MD, PhD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy
Bologna, Emilia-Romagna, Italy

Disclosure information not submitted.

Presentation(s):

• RESPONSE TO MIFAMURTIDE AND TUMOR MICROENVIRONMENT: A DECONVOLUTION NANOSTRING ANALYSIS IN LOCALIZED OSTEOSARCOMA PATIENTS TREATED WITHIN THE ISG/OS2 CLINICAL TRIAL

  Wednesday, November 13, 2024
  1:00 PM – 2:45 PM PST